Levetiracetam
ApprovedCompleted 0 views this week 0 watching⚡ Active
Interest: 43/100
43
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Alcoholism
Conditions
Alcoholism
Trial Timeline
Jan 1, 2006 → Oct 1, 2009
NCT ID
NCT00325182About Levetiracetam
Levetiracetam is a approved stage product being developed by UCB for Alcoholism. The current trial status is completed. This product is registered under clinical trial identifier NCT00325182. Target conditions include Alcoholism.
What happened to similar drugs?
3 of 8 similar drugs in Alcoholism were approved
Approved (3) Terminated (1) Active (4)
Hype Score Breakdown
Clinical
20
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (20)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03340064 | Phase 3 | Completed |
| NCT01618877 | Phase 1 | Completed |
| NCT01407523 | Phase 2 | Completed |
| NCT01398956 | Phase 3 | Completed |
| NCT01292837 | Phase 3 | Completed |
| NCT01063764 | Phase 3 | Completed |
| NCT00505934 | Phase 2 | Completed |
| NCT00627133 | Phase 2 | Withdrawn |
| NCT00535392 | Phase 2 | Completed |
| NCT00376766 | Phase 3 | Terminated |
| NCT00361010 | Pre-clinical | Completed |
| NCT01318408 | Approved | Completed |
| NCT00367432 | Phase 3 | Completed |
| NCT00291655 | Phase 3 | Completed |
| NCT00324454 | Phase 2 | Completed |
| NCT00319605 | Pre-clinical | Completed |
| NCT00307450 | Approved | Completed |
| NCT00279617 | Phase 3 | Completed |
| NCT00325182 | Approved | Completed |
| NCT00252954 | Approved | Completed |
Competing Products
18 competing products in Alcoholism